Merajver SD - Search Results

1

Insights into the modular design of kinase inhibitors and application to Abl and Axl.

Phadke S, Lopez-Barcons L, Vandecan N, Wu Z, Johnson TK, Lachacz EJ, Merajver SD, Soellner MB. Phadke S, et al. Among authors: merajver sd. RSC Med Chem. 2021 Nov 5;13(1):64-71. doi: 10.1039/d1md00296a. eCollection 2022 Jan 27. RSC Med Chem. 2021. PMID: 35224497 Free PMC article.

2

RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype.

van Golen KL, Wu ZF, Qiao XT, Bao LW, Merajver SD. van Golen KL, et al. Among authors: merajver sd. Cancer Res. 2000 Oct 15;60(20):5832-8. Cancer Res. 2000. PMID: 11059780

3

RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells.

van Golen KL, Wu ZF, Qiao XT, Bao L, Merajver SD. van Golen KL, et al. Among authors: merajver sd. Neoplasia. 2000 Sep-Oct;2(5):418-25. doi: 10.1038/sj.neo.7900115. Neoplasia. 2000. PMID: 11191108 Free PMC article.

4

Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability.

Kleer CG, van Golen KL, Zhang Y, Wu ZF, Rubin MA, Merajver SD. Kleer CG, et al. Among authors: merajver sd. Am J Pathol. 2002 Feb;160(2):579-84. doi: 10.1016/S0002-9440(10)64877-8. Am J Pathol. 2002. PMID: 11839578 Free PMC article.

5

WISP3 is a novel tumor suppressor gene of inflammatory breast cancer.

Kleer CG, Zhang Y, Pan Q, van Golen KL, Wu ZF, Livant D, Merajver SD. Kleer CG, et al. Among authors: merajver sd. Oncogene. 2002 May 9;21(20):3172-80. doi: 10.1038/sj.onc.1205462. Oncogene. 2002. PMID: 12082632

6

Detection of Epstein-Barr virus in rapidly growing fibroadenomas of the breast in immunosuppressed hosts.

Kleer CG, Tseng MD, Gutsch DE, Rochford RA, Wu Z, Joynt LK, Helvie MA, Chang T, Van Golen KL, Merajver SD. Kleer CG, et al. Among authors: merajver sd. Mod Pathol. 2002 Jul;15(7):759-64. doi: 10.1038/modpathol.3880602. Mod Pathol. 2002. PMID: 12118114

7

Reversion of RhoC GTPase-induced inflammatory breast cancer phenotype by treatment with a farnesyl transferase inhibitor.

van Golen KL, Bao L, DiVito MM, Wu Z, Prendergast GC, Merajver SD. van Golen KL, et al. Among authors: merajver sd. Mol Cancer Ther. 2002 Jun;1(8):575-83. Mol Cancer Ther. 2002. PMID: 12479217

8

WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer.

Kleer CG, Zhang Y, Pan Q, Gallagher G, Wu M, Wu ZF, Merajver SD. Kleer CG, et al. Among authors: merajver sd. Breast Cancer Res. 2004;6(1):R110-5. doi: 10.1186/bcr755. Breast Cancer Res. 2004. PMID: 14696649 Free PMC article.

9

RhoC induces differential expression of genes involved in invasion and metastasis in MCF10A breast cells.

Wu M, Wu ZF, Kumar-Sinha C, Chinnaiyan A, Merajver SD. Wu M, et al. Among authors: merajver sd. Breast Cancer Res Treat. 2004 Mar;84(1):3-12. doi: 10.1023/B:BREA.0000018426.76893.21. Breast Cancer Res Treat. 2004. PMID: 14999149 Free article.

10

RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast.

Kleer CG, Griffith KA, Sabel MS, Gallagher G, van Golen KL, Wu ZF, Merajver SD. Kleer CG, et al. Among authors: merajver sd. Breast Cancer Res Treat. 2005 Sep;93(2):101-10. doi: 10.1007/s10549-005-4170-6. Breast Cancer Res Treat. 2005. PMID: 16187229 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters